EMV vs MYX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

EMV

EMVISION FPO [EMV]

51MEDIUM

MYX

M PHARMA FPO [MYX]

51MEDIUM

Score Breakdown

EMV MYX
Technical
65
51
Catalyst
50
53
Sentiment
50
50
Fundamental
70
85
Momentum
39
38
Risk Gate
50
42

Key Metrics

EMV Metric MYX
$139.9MMarket Cap$233.2M
37KAvg Volume (20d)291K
N/AShort Interest+2.5%
$2.43052-Week High$6.500
$1.47052-Week Low$2.040
+3.0%Daily Change-0.7%
$1.550Reference Price$2.810
-58.0%ROE-20.6%
-188.0%Profit Margin-20.4%

Active Signals

EMV Signals

●MACD momentum is picking up steam
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Below the 200-day average — the long-term trend is still working against it
●Adequate cash runway (8 quarters)
●Moderate revenue growth (+11%)
●EPS estimates revised upward (+6pts)
●Near 52-week low (4% of range)
●Deeply negative margins (-188%)

MYX Signals

●Beating the Small Ords index — relative strength of 1.29, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.6x)
●EPS estimates revised upward (+10pts)
●Near 52-week low (19% of range)
●CANSLIM I: Institutional ownership (36%)
●Deeply negative margins (-20%)

Ask Scout AI to compare EMV and MYX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

EMV vs PAR →EMV vs PEB →EMV vs SPL →ENL vs HIQ →ENL vs LGP →
EMV Full Analysis → MYX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).